GLOW and KLOW are the two most-compared blends in this catalog, and the comparison is simpler than most: KLOW is GLOW plus one additional component. What that fourth component adds is the whole question.
- GLOW
- GHK-Cu + BPC-157 + TB-500
- KLOW
- GLOW + KPV
- The K
- KPV, a tripeptide
- Supplied as
- Lyophilized powder
The short answer
GLOW is a three-component research blend: GHK-Cu, BPC-157 and TB-500. KLOW is the same three plus KPV, a tripeptide studied in inflammatory-signalling models. The K in KLOW is KPV. Everything else about the two blends is shared.
| Component | GLOW | KLOW |
|---|---|---|
| GHK-Cu | Yes | Yes |
| BPC-157 | Yes | Yes |
| TB-500 | Yes | Yes |
| KPV | No | Yes |
What the shared core contributes
The three components common to both blends are each studied in repair-related research from different directions: GHK-Cu as a copper-carrying tripeptide with a long published literature, BPC-157 in angiogenic and gastrointestinal rodent models, and TB-500 in actin-binding and cell-migration work. The blends exist because those research angles are complementary rather than duplicative.
What KPV adds
KPV is a tripeptide corresponding to the C-terminal fragment of alpha-MSH. Published research on it centres on inflammatory signalling pathways, which is a different research area from the repair and angiogenesis focus of the other three. That is the distinction between the two blends: KLOW extends the composition into inflammatory-pathway research.
Evidence note
Blends are not separately studied as blends. The published literature covers the individual components, and there is no body of trial data on these specific four-component or three-component combinations. Research designs should account for that – the evidence available describes each constituent, not the mixture.
All compounds referenced here are supplied as analytical-grade reference materials for in-vitro and laboratory research only. Nothing on this page is a recommendation for human or veterinary use, and no comparison below should be read as ranking these materials for any personal outcome.
Studies cited
- GHK as an anti-aging peptide (Aging pathobiology and therapeutics, 2020)
- GHK peptide and skin-regeneration pathways (BioMed research international, 2015)
- GHK-Cu skin permeation in liposomes (Molecules (Basel, Switzerland), 2025)
- BPC-157 and musculoskeletal soft-tissue healing (Cell and tissue research, 2019)
- BPC-157 and wound healing (Frontiers in pharmacology, 2021)
- BPC-157 in tissue repair & pain research (International journal of molecular sciences, 2026)
Questions
What does the K in KLOW stand for?
The K in KLOW is KPV, a tripeptide corresponding to the C-terminal fragment of alpha-MSH. KLOW is the GLOW blend with KPV added as a fourth component.
What is in the GLOW blend?
The GLOW blend contains three components: GHK-Cu, BPC-157 and TB-500. Each is studied in repair-related research from a different mechanistic direction.
Is KLOW just a stronger version of GLOW?
No. KLOW is not a higher-concentration GLOW – it is GLOW plus KPV, a component studied in inflammatory-signalling research rather than in the repair and angiogenesis work behind the other three. The difference is compositional, not a matter of strength.
Is there research on these blends specifically?
The published literature covers the individual components of GLOW and KLOW rather than the blends themselves. There is no body of trial data on these specific combinations, so the available evidence describes each constituent separately.
For laboratory research and educational purposes only. Not medical advice. The materials discussed are not for human or animal consumption and have not been evaluated by the FDA.